Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes.
Malecki
Maciej T
MT
Department of Metabolic Diseases, Jagiellonian University, 15 Kopernika St., 31-501 Krakow, Poland. malecki_malecki@yahoo.com
Undas
Anetta
A
Cyganek
Katarzyna
K
Mirkiewicz-Sieradzka
Barbara
B
Wolkow
Pawel
P
Osmenda
Grzegorz
G
Walus-Miarka
Malgorzata
M
Guzik
Tomasz J
TJ
Sieradzki
Jacek
J
D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry; D015415:Biomarkers / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications*; D003930:Diabetic Retinopathy / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D015999:Multivariate Analysis; D009569:Nitric Oxide / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D012044:Regression Analysis
D015415:Biomarkers; C487735:dimethylarginine; D009569:Nitric Oxide; D001120:Arginine; D003404:Creatinine; D019001:Nitric Oxide Synthase